Dataset

life-science-intelligence

Research and intelligence covering pharmaceutical products, clinical trials, patent filings and regulatory progress.

Dataset card

Life Science Intelligence is a commercial dataset published by Clarivate covering the pharmaceutical and biotechnology research lifecycle. The provider aggregates information on drugs, clinical trials, patents, and regulatory filings into a single intelligence product.

What this dataset contains

The product combines four core domains indicated by its tags: drugs, clinical trials, patents, and regulatory activity. Coverage spans the full life-sciences value chain from early-stage discovery through post-marketing regulatory events. Exact row counts, country coverage, and update frequency are not disclosed in the available metadata.

Structure and fields

Clarivate has not published a public schema, and the column list for this dataset is listed as unknown. No sample rows are available for review, so analysts cannot confirm field-level granularity such as trial phase codes, patent claim types, or approval identifiers. Customers typically access the data through Clarivate's own platforms and APIs rather than a downloadable flat file.

How analysts use it

Healthcare-focused investors use the underlying drugs, trials, patents, and regulatory streams to map competitor pipelines, anticipate FDA decision catalysts, and assess freedom-to-operate risk around specific molecules. The commercial license means access is generally restricted to paying subscribers and institutional clients rather than the open research community.

Documentation & references 2